Beijing, Shanghai and Hong Kong – March 6, 2026 – Cooley was recognized for its outstanding work in areas of intellectual property (life sciences corporate partnering and licensing), equity capital markets, and private equity (PE) and venture capital (VC), securing recognitions with five standout deals in the Chinese market in China Business Law Journal’s 2025 Deals of the Year awards.

The awards recognize significant deals and transactions completed between November 2024 and October 2025.

The firm was recognized in connection with deals in:

Intellectual property (life sciences corporate partnering and licensing):

Equity capital markets:

PE and VC:

Cooley has maintained a deep-rooted presence in Greater China for many years, drawing on its extensive understanding of the region’s innovation ecosystem and its knowledge of global capital market regulations.

We provide forward-looking legal support to companies across the technology, healthcare and life sciences sectors. Beyond advising on key transactions, we partner with our clients throughout their growth journey – from startup to maturity, and from local growth to global expansion. Whether navigating complex cross-border compliance issues or designing highly tailored transaction structures, Cooley’s team remains results-driven, helping clients execute their strategic goals efficiently in an ever-evolving market landscape.

The China Business Law Journal “Deals of the Year” awards recognize landmark transactions and cases that serve as models in the market. The 2025 awards cover deals that were signed, closed, concluded or achieved significant milestones between November 1, 2024, and October 31, 2025. The judging panel evaluates submissions based on factors such as market impact, legal complexity, structural innovation, industry influence and long-term value created for clients and society. From numerous entries, the panel selects representative cases that showcase high-quality legal services and outstanding transactional practices within the industry.

Cooley: Three decades of commitment to China

For nearly 40 years, Cooley has leveraged its offices in Shanghai, Beijing and Hong Kong to provide comprehensive legal services to companies and investors in China and around the world.

We advise some of China’s most innovative and dynamic technology and life sciences companies, as well as top institutional investors, on matters including fund formation, financing, mergers and acquisitions, joint ventures, capital markets, licensing and other strategic cross-border transactions.

Cooley partners with clients at every stage of their growth – from startup to maturity – delivering legal support across the entire corporate life cycle.

About Cooley LLP

Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation.

Cooley has nearly 1,400 lawyers across 19 offices in the United States, Asia and Europe, and a total workforce of more than 3,000 people.

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as "Cooley"). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. When advising companies, our attorney-client relationship is with the company, not with any individual. This content may have been generated with the assistance of artificial intelligence (Al) in accordance with our Al Principles, may be considered Attorney Advertising and is subject to our legal notices.